TITLE

Cytomorphological Effects of Mitomycin C on Urothelial Cells: Eosinophils May Be Clue to The Drug-Induced Changes

AUTHOR(S)
Simsek, Gulcin Guler; Vargol, Erdem; Simsek, Hulya
PUB. DATE
September 2014
SOURCE
Cell Journal (Yakhteh);Autumn2014, Vol. 16 Issue 3, p375
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cytomorphological changes of mitomycin C on urothelial cells may be misinterpreted as a neoplastic process. A 60-year old male patient who was given an eight-week course of intravesical mitomycin C due to non-invasive low grade transitional cell carcinoma. During his follow-up care, the findings of a urine cytology exam were as follows: nuclear enlargement of cells, wrinkled nuclear membranes, little hyperchromasia, pleomorphism, abnormal nuclear morphology and disordered orientation of the urothelium. Furthermore, there were eosinophils nearby the atypical cells. This report aimed at reminding the cytomorphologic changes of mitomycin C may be misinterpreted as carcinoma, so the presence of eosinophils is required to predict the drug-induced changes.
ACCESSION #
98850504

 

Related Articles

  • Third Place: Increasing Dwell Time of Mitomycin C in the Upper Tract with a Reverse Thermosensitive Polymer. Wang, Agnes J.; Goldsmith, Zachariah G.; Neisius, Andreas; Astroza, Gaston M.; Oredein-McCoy, Olugbemisola; Iqbal, Muhammad W.; Simmons, W. Neal; Madden, John F.; Preminger, Glenn M.; Inman, Brant A.; Lipkin, Michael E.; Ferrandino, Michael N. // Journal of Endourology;Mar2013, Vol. 27 Issue 3, p288 

    Background and Purpose: Topical chemotherapy for urothelial cancer is dependent on adequate contact time of the chemotherapeutic agent with the urothelium. To date, there has not been a reliable method of maintaining this contact for renal or ureteral urothelial carcinoma. We evaluated the...

  • Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study. Florianova, Livia; Bin Xu; Traboulsi, Samer; Elmansi, Hazem; Tanguay, Simon; Aprikian, Armen; Kassouf, Wassim; Brimo, Fadi // World Journal of Surgical Oncology;11/14/2015, Vol. 16, p1 

    Background: RNA-binding motif protein 3 (RBM3), involved in cell survival, has paradoxically been linked to both oncogenesis as well as an increased survival in several cancers, including urothelial carcinoma (UCA). Methods: The putative prognostic role of RBM3 was studied using cystectomy...

  • Secretory Carcinoma of the Breast: Report of Two Cases and Review of the Literature. Sharma, Vivekanand; Anuragi, Gajendra; Singh, Suresh; Patel, Pinakin; Jindal, Arpita; Sharma, Raj Govind // Case Reports in Oncological Medicine;7/5/2015, Vol. 2015, p1 

    Secretory carcinoma of the breast is an extremely rare subtype of breast cancer characterized by intracellular or extracellular secretion and granular eosinophilic cytoplasm of the neoplastic cells. The disease which was considered to be predominant in younger age group has been recognized in...

  • Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis. Lyle, Stephen R.; Hsieh Chung-Cheng; Fernandez, Cecilia A.; Shuber, Anthony P. // Research & Reports in Urology;2012, Issue 4, p65 

    Background: Mutations in FGFR3 have been shown to occur in tumors of the upper urothelial tract and may be indicative of a good prognosis. In bladder tumors, the combination of FGFR3 mutation status and Ki-67 level has been used to define a tumor's molecular grade and predict survival....

  • Intracavitary Immunotherapy and Chemotherapy for Upper Urinary Tract Cancer: Current Evidence. Carmignani, Luca; Bianchi, Roberto; Cozzi, Gabriele; Grasso, Angelica; Macchione, Nicola; Marenghi, Carlo; Melegari, Sara; Rosso, Marco; Tondelli, Elena; Maggioni, Augusto // Reviews in Urology;2013, Vol. 15 Issue 4, p145 

    A review of the literature was performed to summarize current evidence regarding the efficacy of topical immunotherapy and chemotherapy for upper urinary tract urothelial cell carcinoma (UUT-UCC) in terms of post-treatment recurrence rates. A Medline database literature search was performed in...

  • Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. Simpson, G R; Horvath, A; Annels, N E; Pencavel, T; Metcalf, S; Seth, R; Peschard, P; Price, T; Coffin, R S; Mostafid, H; Melcher, A A; Harrington, K J; Pandha, H S // British Journal of Cancer;1/31/2012, Vol. 106 Issue 3, p496 

    Background:There are still no effective treatments for superficial bladder cancer (SBC)/non-muscle invasive bladder cancer. Following treatment, 20% of patients still develop metastatic disease. Superficial bladder cancer is often multifocal, has high recurrences after surgical resection and...

  • Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract. Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 12, p4734 

    Bladder tumor recurrence after surgery for upper urinary tract urothelial carcinoma (UUT-UC) is frequent. Intravesical instillation has been widely accepted as an effective way to prevent bladder tumor recurrence. We aimed to find whether postoperative instillation have benefits for bladder...

  • Il trattamento integrato con ipertermia e chemioterapia nel tumore vescicale non muscolo-invasivo.  // Urologia;2009, Vol. 76 Issue 2, p61 

    No abstract available.

  • Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma. Aboumarzouk, Omar M.; Somani, Bhaskar; Ahmad, Sarfraz; Nabi, Ghulam; Townell, Nicholas; Kata, Slawomir G. // Urology Annals;Jul2013, Vol. 5 Issue 3, p184 

    Introduction: Instillation of Mitomycin C (MMC) should prevent implantation of cancer cells released during endoscopic treatment and prevent recurrences as seen in carcinoma of the bladder. Aim: To develop and evaluate a protocol for a single dose MMC instillation following Holmium: YAG laser...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics